Editorial: Is it time to separate EPA from DHA when using omega-3 fatty acids to protect heart and brain?

Curr Opin Clin Nutr Metab Care. 2020 Mar;23(2):65-67. doi: 10.1097/MCO.0000000000000632.

Authors

Richard J Deckelbaum¹, Philip C Calder^{2

3}

Affiliations

¹ Department of Pediatrics, Institute of Human Nutrition, Columbia University Irving Medical Center, New York, New York, USA.
² School of Human Development and Health, Faculty of Medicine, University of Southampton.
³ NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, UK.

PMID: 32028319
DOI: 10.1097/MCO.0000000000000632

No abstract available

Publication types

Editorial

MeSH terms

Brain / drug effects
Dietary Supplements*
Docosahexaenoic Acids / pharmacology*
Eicosapentaenoic Acid / pharmacology*
Fatty Acids, Omega-3 / chemistry*
Heart / drug effects
Humans
Protective Agents / pharmacology*

Substances

Fatty Acids, Omega-3
Protective Agents
Docosahexaenoic Acids
Eicosapentaenoic Acid